Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Repligen Corp shares valued at $331,301 were sold by Bylund James on Nov 18 ’25. At $151.21 per share, Bylund James sold 2,191 shares. The insider’s holdings dropped to 21,520 shares worth approximately $3.34 million following the completion of this transaction.
Also, Bylund James purchased 2,191 shares, netting a total of over 331,304 in proceeds.
Before that, Hunt Anthony had sold 20,000 shares from its account. In a trade valued at $3,092,278, the Director traded Repligen Corp shares for $154.61 each. Upon closing the transaction, the insider’s holdings decreased to 20,000 shares, worth approximately $12.52 million.
As published in their initiating research note from HSBC Securities on October 01, 2025, Repligen Corp [RGEN] has been a Buy and the price target has been revised to $150. Analysts at Evercore ISI upgraded the stock from ‘”an In-line”‘ to ‘”an Outperform”‘ outlook in a report released in late September. Earlier on June 24, 2025, Barclays initiated its rating. Their recommendation was “an Overweight” for RGEN stock.
Analyzing RGEN Stock Performance
On last trading session, Repligen Corp [NASDAQ: RGEN] rose 1.32% to $155.08. The stock’s lowest price that day was $150.26, but it reached a high of $155.82 in the same session. During the last five days, there has been a drop of approximately -1.85%. Over the course of the year, Repligen Corp shares have jumped approximately 24.33%. Shares of the company reached a 52-week high of $182.52 on 01/28/25 and a 52-week low of $102.96 on 04/07/25.
Support And Resistance Levels for Repligen Corp (RGEN)
According to the 24-hour chart, there is a support level at 151.62, which, if violated, would cause prices to drop to 148.16. In the upper region, resistance lies at 157.18. The next price resistance is at 159.28. RSI (Relative Strength Index) is 56.36 on the 14-day chart, showing neutral technical sentiment.
Is Repligen Corp subject to short interest?
Stocks of Repligen Corp saw a sharp steep in short interest on 2025-10-31 dropping by 93938.0 shares to 3.32 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 3.41 million shares. A decline of -2.83% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.86 of the overall float, the days-to-cover ratio (short ratio) decline to 2.86.
Which companies own the most shares of Repligen Corp (RGEN)?
In terms of Repligen Corp share price expectations, FactSet research, analysts set an average price target of 165 in the next 12 months, up nearly 7.8% from the previous closing price of $153.06. Analysts anticipate Repligen Corp stock to reach 205 by 2025, with the lowest price target being 150. In spite of this, 9 analysts ranked Repligen Corp stock as Buy at the end of 2025. On April 29, 2025, Wolfe Research assigned a price target of “an Outperform” to the stock and upgraded coverage with a $160.
